Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
BACKGROUND
Breast cancer (BrCa) is the most commonly diagnosed cancer among women in the industrialized world. More than half of women presenting with metastatic BrCa develop bone metastases. Bone metastases increase the risk of skeletal-related events (SREs), defined as pathological fractures, spinal cord compression, bone pain requiring palliative radiotherapy, and orthopaedic surgery. Both bone metastases and SREs are associated with unfavorable prognosis and greatly affect quality of life. Few epidemiological data exist on SREs after primary diagnosis of BrCa and subsequent bone metastasis. We therefore estimated the incidence of bone metastases and SREs in newly-diagnosed BrCa patients in Denmark from 1999 through 2007.


METHODS
We estimated the overall and annual incidence of bone metastases and SREs in newly-diagnosed breast cancer patients in Denmark from January 1, 1999 to December 31, 2007 using the Danish National Patient Registry (DNPR), which covers all Danish hospitals. We estimated the cumulative incidence of bone metastases and SREs and associated 95% confidence intervals (CI) using the Kaplan-Meier method.


RESULTS
Of the 35,912 BrCa patients, 178 (0.5%) presented with bone metastases at the time of primary breast cancer diagnosis, and of these, 77 (43.2%) developed an SRE during follow up. A total of 1,272 of 35,690 (3.6%) BrCa patients without bone metastases at diagnosis developed bone metastases during a median follow-up time of 3.4 years. Among these patients, 590 (46.4%) subsequently developed an SRE during a median follow-up time of 0.7 years. Incidence rates of bone metastases were highest the first year after the primary BrCa diagnosis, particularly among patients with advanced BrCa at diagnosis. Similarly, incidence rates of a first SRE was highest the first year after first diagnosis of a bone metastasis.


CONCLUSIONS
The high incidence of SREs following the first year after first diagnosis of a bone metastasis underscores the need for early BrCa detection and research on effective treatments to delay the onset of SREs.
Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Alle 1150, DK-8000 Århus C., Denmark.
Annette Ø
AØ
Jensen
Jacob B
JB
Jacobsen
Mette
M
Nørgaard
Mellissa
M
Yong
Jon P
JP
Fryzek
Henrik T
HT
Sørensen
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000453:epidemiology* / Q000556:secondary; D001943:Breast Neoplasms / Q000150:complications / Q000453:epidemiology* / Q000473:pathology; D015331:Cohort Studies; D003718:Denmark / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D010146:Pain / Q000453:epidemiology* / Q000209:etiology; D012042:Registries / Q000706:statistics & numerical data; D013117:Spinal Cord Compression / Q000453:epidemiology*; D055815:Young Adult
J Clin Oncol. 1998 Jun;16(6):2038-44
9626201
Stat Med. 1999 Mar 30;18(6):695-706
10204198
Clin Epidemiol. 2009 Aug 09;1:101-8
20865091
Breast Cancer Res Treat. 2009 May;115(2):423-8
18543098
N Engl J Med. 1996 Dec 12;335(24):1785-91
8965890
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
Inflamm Bowel Dis. 2008 Apr;14(4):519-25
18069672
Cancer Lett. 2009 Jan 18;273(2):177-93
18632203
Br J Cancer. 1987 Jan;55(1):61-6
3814476
Cancer Causes Control. 2008 Feb;19(1):97-106
18038250
Dan Med Bull. 1999 Jun;46(3):263-8
10421985
Rofo. 2009 Dec;181(12):1144-50
19859859
Lancet Oncol. 2010 May;11(5):421-8
20362507
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Endocr Rev. 1998 Feb;19(1):80-100
9494781
Science. 2000 Mar 31;287(5462):2398-9
10766613